CD33 and acute myeloid leukemia: Our group extended this approach to RIT of acute myeloid leukemia (AML) using 111In-labelled anti-CD33 murine M195 and humanised HuM195 mAbs (Chen et al. 2006) similarly modified with NLS peptides to promote nuclear importation.